» Articles » PMID: 17764510

A Sensitive Quantitative Single-platform Flow Cytometry Protocol to Measure Human Platelets in Mouse Peripheral Blood

Overview
Journal Transfusion
Specialty Hematology
Date 2007 Sep 4
PMID 17764510
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The NOD/SCID mouse is a widely used model for human cord blood (CB) transplantation. Engraftment is generally estimated with semiquantitative methods, measuring the percentage of human cells among mouse cells. To compare protocols aiming to improve hematopoietic recovery, quantitative methods to enumerate human cells would be preferred. This study describes a single-platform protocol to count human platelets (hPLTs) after transfusion and CB transplantation in the peripheral blood (PB) of the mouse.

Methods: With an anti-human CD41 antibody against hPLTs and counting beads, the sensitivity to detect hPLTs in mouse blood by flow cytometry was validated. PLT recovery after hPLT transfusions and PLT kinetics after transplantation with CB CD34+ cells was followed in time in NOD/SCID mice.

Results: hPLTs could be reliably detected to a level as low as 1 PLT per microL with this single-platform protocol, what appeared to be at least 10 times more sensitive than detection with the dual-platform protocol. To verify the applicability for mouse studies, hPLTs were measured serially in transfusion and transplantation studies in NOD/SCID mice. The results showed that earlier detection of PLT recovery was feasible with the single-platform protocol.

Conclusion: A single-platform flow cytometry method can repeatedly measure low numbers of circulating hPLTs in the PB of the same mouse. This method may be helpful in search of new protocols aiming at accelerating PLT recovery after CB transplantation, but also in a number of clinical settings, such as monitoring PLT reconstitution after hematopoietic stem cell transplantation.

Citing Articles

AA2P-mediated DNA demethylation synergizes with stem cell agonists to promote expansion of hematopoietic stem cells.

Manesia J, Maganti H, Almoflehi S, Jahan S, Hasan T, Pasha R Cell Rep Methods. 2023; 3(12):100663.

PMID: 38070507 PMC: 10783628. DOI: 10.1016/j.crmeth.2023.100663.


Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes.

Schmitt N, Jann J, Altrock E, Flach J, Danner J, Uhlig S Leukemia. 2021; 36(1):236-247.

PMID: 34172896 PMC: 8727300. DOI: 10.1038/s41375-021-01327-w.


No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice.

van der Garde M, Brand A, Slot M, De Graaf-Dijkstra A, Zwaginga J, van Hensbergen Y Stem Cells Dev. 2015; 24(12):1448-56.

PMID: 25668618 PMC: 4485368. DOI: 10.1089/scd.2014.0543.


Thrombopoietin treatment of one graft in a double cord blood transplant provides early platelet recovery while contributing to long-term engraftment in NSG mice.

van der Garde M, van Hensbergen Y, Brand A, Slot M, De Graaf-Dijkstra A, Mulder A Stem Cells Dev. 2014; 24(1):67-76.

PMID: 25137252 PMC: 4273186. DOI: 10.1089/scd.2014.0294.


Detection of human hematopoietic stem cell engraftment in the livers of adult immunodeficient mice by an optimized flow cytometric method.

Varga N, Barcena A, Fomin M, Muench M Stem Cell Stud. 2011; 1(1).

PMID: 21603093 PMC: 3098741. DOI: 10.4081/scs.2010.e5.